Abstract
After much investigation, we realized that there is a flaw in Figure 2. One of the spectra was wrongly placed in the image (by one of the students) and should be removed. The revised (corrected) Figure 2 is below. In the Figure 2 caption, the term of “spectra” for XRD changes to “pattern”. Also, Figure 7f and Figure 10f,g are replaced with the new images as listed below. Also, in the text, the sentence “The broadening in the diffraction peaks corresponds to the presence of DOX (after incorporation) and the byproducts” should be changed to “The broadening in the diffraction peaks corresponds to the presence of leaf extracts and the byproducts.” (Figure Presented).
| Original language | English |
|---|---|
| Pages (from-to) | 1313-1314 |
| Number of pages | 2 |
| Journal | ACS Applied Bio Materials |
| Volume | 6 |
| Issue number | 3 |
| DOIs |
|
| Publication status | Published - 20 Mar 2023 |
ASJC Scopus subject areas
- Biomaterials
- General Chemistry
- Biomedical Engineering
- Biochemistry (medical)
Fingerprint
Dive into the research topics of 'Erratum: Turning Toxic Nanomaterials into a Safe and Bioactive Nanocarrier for Co-delivery of DOX/pCRISPR (ACS Applied Bio Materials (2021) 4: 6 (5336−5351) DOI: 10.1021/acsabm.1c00447)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver